• Explore /
  • Poster
  • / Association of statins and nivolumab activity in patients with metastatic renal cell carcinoma (mRCC): Results from the phase II nivoren—GETUG AFU 26 trial.

Association of statins and nivolumab activity in patients with metastatic renal cell carcinoma (mRCC): Results from the phase II nivoren—GETUG AFU 26 trial.

Abstract Poster

Authors

null

Emeline Colomba

Gustave Roussy Cancer Campus, Paris Saclay University, Villejuif, France

Emeline Colomba , Ronan Flippot , Cécile Dalban , Sylvie Negrier , Christine Chevreau , Gwenaelle Gravis , Stephane Oudard , Brigitte Laguerre , Philippe Barthelemy , Marine Gross Goupil , Lionnel Geoffrois , Frederic Rolland , Antoine Thiery-Vuillemin , Florence Joly , Sylvain Ladoire , Florence Tantot , Bernard Escudier , Laurence Albiges

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Other

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 359)

DOI

10.1200/JCO.2021.39.6_suppl.359

Abstract #

359

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Emeline Colomba

First Author: Cristina Masini

First Author: Suzanne Phillips

First Author: Kohei Shitara